STAT+: Pharmalittle: Novo’s Wegovy obesity drug lowers cardiovascular risk in key trial; Nektar accuses Lilly of ‘misconduct’ in development deal
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
Category: Pharmalot
.jpg)
STAT+: Nektar Therapeutics sues Lilly for ‘misconduct’ in drug development deal
A behind-the-scenes feud over a drug development program erupted into public view as Nektar Therapeutics…
STAT+: Pharmalittle: FDA OKs Sage drug for postpartum depression; major U.S. health systems to offer Alzheimer’s drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: White House drug-shortage task force brainstorms fixes; U.S. pharma layoffs are ballooning
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Vertex faces renewed calls to widen access to its cystic fibrosis medicines in poor countries
Several Latino advocacy groups and more than 100 clinicians from dozens of countries are lending…
STAT+: Pharmalittle: Patients brace for insurance decisions on weight loss drugs; Indian authorities find multiple problems at pharma plants
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT+: Pharmalittle: Some employers cut insurance coverage for weight loss drugs; U.S. urges ADHD pill makers to boost production
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Intas Pharma employee used acid to destroy manufacturing records at troubled plant
Last November, an employee at Intas Pharmaceuticals, which makes several widely used chemotherapies that are…
STAT+: Pharmalittle: Medicare looks to improve Alzheimer’s care but sidesteps drug prices; CVS to cut 5,000 jobs
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT+: Pharmalittle: House Republicans and Democrats duel over drug shortages; FDA approves second over-the-counter naloxone
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Pharma hopes reformulated drugs will skirt Medicare negotiations; Biogen to acquire Reata for $7.3 billion
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly
More than two dozen prominent health policy experts are urging the Biden administration to ensure…
STAT+: Pharmalittle: House Dems push new bill for Medicare drug negotiations; WHO leaves obesity drugs off essential medicines list
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: European Commission accelerates phasing out animal testing, but stops short of a ban
After months of deliberation, the European Commission has agreed to accelerate the phasing out of…
STAT+: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls
One of the largest compound pharmacy operations in the U.S. recently recalled a slew of…
STAT+: Pharmalittle: State Medicaid programs seek discounts for Wegovy; congressional PBM bills work around the fringes
Top of the morning to you. And a fine one it is. Lots of sunshine…
STAT+: South Africa faces court hearing over opaque Covid-19 vaccine contracts
A hearing began in a South Africa court on Tuesday to determine whether the government…
STAT+: Pharmalittle: Biogen to slash 1,000 more jobs; key House panel proposes lowering Medicare out-of-pocket drug costs
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Pharmalittle: Three big drugmakers spent less on lobbying after leaving PhRMA; EMA reviews CRO over data concerns
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pfizer says most tornado damage at key plant hit warehouse, but finished drugs also impacted
Pfizer says a tornado that ripped through a key manufacturing plant in North Carolina does…
STAT+: Major pharma companies call on their suppliers to reduce carbon footprints
As anxiety mounts over climate change, seven of the world’s largest drugmakers urged dozens of…
STAT+: European regulator will review study data from contract research organization due to ‘serious concerns’
In the latest melee over the safety of prescription medicines, the European Medicines Agency is…
STAT+: Pharmalittle: Sanders wants to replace drug patents with prizes for innovation; FDA approves an anthrax vaccine
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Damages from tornado at Pfizer plant could compound challenges of drug shortages
The tornado that struck parts of North Carolina on Wednesday not only damaged the immediate…
STAT+: Pharmalittle: Health care mergers facing tougher antitrust scrutiny; tornado hits Pfizer plant and more shortages may result
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: FTC plans to reverse years of policy statements supporting pharmacy benefit managers
The U.S. Federal Trade Commission is reversing years of prior advocacy in support of pharmacy…
STAT+: House committee probes FDA inspections of pharma plants in China and India
A Congressional committee is demanding the U.S. Food and Drug Administration provide detailed information about…
STAT+: Pharmalittle: J&J is third drugmaker to sue over Medicare negotiations; Teva faces trial over Medicare kickbacks
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing
For the third time this year, Novartis has been rebuked by a U.K. trade group…
STAT+: Pharmalittle: Data confirm benefits and risks of Lilly Alzheimer’s drug; Medicare aims to pay hospitals to stockpile essential drugs
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Colombian government explores compulsory licensing for an HIV drug
The latest clash over the cost of a prescription medicine is playing out in Colombia,…
STAT+: Pharmalittle: Alzheimer’s diagnosis revamp embraces rating scale similar to cancer; FTC seeks info on Pfizer-Seagen deal
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Key Senate panel has a plan for PBMs; Roivant eyes $7 billion sale of a stomach drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: HHS leader to vaccine makers: Set ‘reasonable’ prices for your next round of Covid-19 vaccines
Amid ongoing controversy over the cost of medicines, a key Biden administration official told Covid-19…
FDA approves first over-the-counter birth control pill
In a highly anticipated move, the U.S. Food and Drug Administration approved the first over-the-counter…
STAT+: Pharmalittle: Congress is letting a drug shortages fix pass it by; FDA voucher program may lapse in October
Rise and shine, folks, another busy day is on the way. Already, there was a…
STAT+: Pharmalittle: EU fines Illumina $475M for closing Grail deal; life-threatening lead poisoning antidote in short supply
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: How to ‘break the logjam’? Economists pitch a plan to curb dire drug shortages
There are alarmingly frequent reports of shortages of vitally needed medicines. From tablets to treat…
STAT+: Pharmalittle: Eisai exec who helped lead Alzheimer’s drug development to retire; Express Scripts adds three Humira biosimilars to preferred formulary
Top of the morning to you, and a fine one it is. Birds are chirping…
STAT+: Pharmalittle: European regulator probes suicidal risks of weight loss drugs; Pfizer reports shortages of penicillin for fighting syphilis
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: FDA grants full approval to Alzheimer’s drug; Sanders blocks NIH nominee over drug costs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Generic group sues Minnesota over a drug pricing transparency law it calls an “unconstitutional overreach”
The trade group for generic drug companies has filed a lawsuit alleging a Minnesota law…
.jpg)
STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling
Top of the morning to you, and a fine one it is. Cool breezes and…
STAT+: NIH halts funding for Colombian facilities accused of abusing animals
The U.S. National Institutes of Health late last month halted funding for a pair of…
STAT+: Pharmalittle: Novo Nordisk spent $11 million on doctors to promote Ozempic and similar drugs; China offers foreign drugmakers an olive branch
Good morning, everyone, and nice to see you again after an extended holiday break, at…
STAT+: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high
In a setback to AIDS activists, a federal court jury on Friday cleared Gilead Sciences…
STAT+: Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Former Pfizer statistician is charged with insider trading over Paxlovid clinical trial results
A former Pfizer statistician on Thursday was charged by U.S. authorities with insider trading for…
STAT+: Pharmalittle: Drug-wholesaler owner indicted for alleged role in diverting HIV medicines; Catalent linked to Regeneron drug rejection
Top of the morning to you. A delicious cool breeze and shiny sun are hovering…
STAT+: Drug wholesaler owner indicted for role in diverting Gilead and J&J HIV medicines
The owner of a pharmaceutical wholesaler has been indicted for his alleged role in distributing…